Artificial Organs Market Size By Organ Type (Artificial Kidney, Artificial Liver, Artificial Lungs, Artificial Pancreas, Artificial Heart), By Material Type (Silicon, Plastic, Steel), Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Nov 2019  |  Report ID: GMI3447  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 130   |   Base Year: 2018




Summary Table of Contents Industry Coverage Methodology

Industry trends

Artificial Organs Market size surpassed $17 billion in 2018 and is projected to achieve over 8.9% CAGR up to 2025.
 

Artificial Organs Market

Get more details on this report - Request Free Sample PDF
 

Artificial organ is a tissue/cell or device-based approach to treat patients with severely damaged organs. These products are mainly used for partial support, regeneration and replacement of diseased, partial functional and damaged organs. With advancement in research and development and to provide more reliable results in organ transplantation, use of tissue engineering techniques and cell therapy is considered.  Presently, new artificial organs based on electro physical, optical, mechanical and other technological characteristics are being developed, using distinct features from cell products and devices.
 

History of artificial organs can be traced back to 400 BC, during which Hippocrates technology tool included ears, eye and brain. With further research development, between 1480-1562, Berlichingen was the initiator of the prothesis progression. In 16th century, Ambroise Pare a French surgeon, developed leg and arm protheses with normal functioning. With continued progress and advancements in artificial organ industry, in 1995, American Society for Internal Artificial Organs was founded by Dr. Peter Salisbury to facilitate the awareness and exchange of knowledge about artificial organs among the population. For instance, with increasing number of patients with kidney failure, scientist at University of California at San Francisco and Vanderbilt University Medical Centre worked collaboratively to develop artificial kidney with the research grant provided by National Institutes of Health. Therefore, with large pool of patients waiting for organ transplant, rising cases of organ failure and increasing awareness about artificial organ transplant will drive the market growth.
 

Artificial Organs Market Report Coverage
Report Coverage Details
Base Year: 2018 Market Size in 2018: 17 Billion (USD)
Historical Data for: 2014 to 2018 Forecast Period: 2019 to 2025
Forecast Period 2019 to 2025 CAGR: 8.9% 2025 Value Projection: 30.9 Billion (USD)
Pages: 130 Tables, Charts & Figures: 144
Geographies covered (20): U.S., Canada, Germany, UK, France, Italy, Spain, Poland, Russia, Turkey, Japan, China, India, Australia, Brazil, Mexico, Argentina, South Africa, Saudi Arabia
Segments covered: Organ type, Material type
Companies covered (11): SynCardia, Nipro Corporation, Ottobock, Berlin Heart GmbH, Cochlear Limited, Baxter International, Medtronic, Boston Scientific Corporation, Zimmer Biomet and Ekso Bionics
Growth Drivers:
  • Scarcity of organ donors globally
  • Increasing incidence of organ failures
  • Growing technological advancements
Pitfalls & Challenges:
  • Product failure after transplantation
  • High cost of artificial organs
  • Rising prevalence of infections due to material used for artificial organ development

Request 15% Free Customization on this Report
 

Scarcity of donors for organ transplantation will offer lucrative growth opportunity for the artificial organ sector  

Rising technological and medical advancements in artificial organ industry is a major factor stimulating the industry growth. Moreover, growing geriatric population base and increasing incidence of chronic disorders, resulting into single or multiple organ failures will fuel the growth of the artificial organs market. According to official statistics, more than 113,000 patients were on the national transplant waiting list in July 2019 in the U.S. However, rising awareness about medical bionics and dearth of organ donors will increase the demand across the forecast years.
 

However, product failure after transplantation and organs susceptibility to infections due to material used in the development of artificial organ will hamper the market growth to certain extent. Moreover, high cost associated with artificial organ transplantation will further limit the business growth.
 

Chronic kidney disorders, considered as “silent diseases”, will dominate the medical bionics market

U.S. Artificial Organs Market, By Organ Type, 2018 (USD Million)
U.S. Artificial Organs Market, By Organ Type, 2018 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Organ type segment is categorised into artificial kidney, artificial liver, artificial lungs, artificial pancreas, artificial heart and others. The artificial kidney segment accounted for over 50.0% market share of the global artificial organs industry in 2018. International Society of Nephrology stated that over 850 million people worldwide suffer from kidney disorders that is roughly the double the number of people diagnosed with diabetes. Around 10.5 million people require transplantation or dialysis. However, a large section of patient population dies due to unavailability of kidney donor and lack of other resources. To reduce the mortality rate due to kidney failure, development of artificial kidney plays a vital role in reducing kidney illnesses and improve the quality of life among the patients. The product also provides continuous blood filtration benefit to remove toxins. Thus, increasing morbidity and mortality rate due to kidney diseases and rising acceptance of bionic organs will play a major role in augmenting the growth of the artificial organs market.
 

Silicon segment will dominate the material type segment of artificial organs market

Based on material, the artificial organs industry is segmented into silicon, plastic, steel and others. Silicon based artificial organs are anticipated to hold maximum revenue of USD 10.8 billion by 2025. High growth is attributed to increasing number of companies adopting silicon as the chief material for artificial organs for its inert and inorganic nature as it can withstand high temperature. For instance, scientists at Functional Materials Laboratory of ETH Zurich University in Switzerland are developing silicon based more soft and durable artificial heart.
 

Increasing number of organ failure cases in Asia Pacific will boost regional growth

Asia Pacific Artificial Organs Market, By Country, 2025 (USD Million)
Asia Pacific Artificial Organs Market, By Country, 2025 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Growing geriatric population base, increasing incidence of organ failure and disabilities coupled with rising demand for advanced medical treatments will spur the growth of Asia Pacific artificial organs market. Growing adoption of sedentary lifestyle, rising number of road accidents leading to amputations are some of the key factors contributing to the growth of the bionic implants market in the Asia Pacific region. Moreover, presence of some of the notable market players including the Nipro Corporation, one of the top two players globally in the production of artificial kidney has positively impacted the market growth.
 

North America market is expected to show significant growth of 8.7% across the forecast timeframe. Increasing number of organ failures, immense technological advancement and presence of major market players will significantly augment the regional growth. National Kidney Foundation reported that, chronic kidney disorders affect nearly 15% of the total the U.S. population. With respect to increasing organ failures, there is scarcity of organ donors, thereby augmenting the use of medical bionics to reduce the rate of mortality among the patients. Moreover, rising prevalence of diabetes leading to multiple organ failure and adoption of sedentary lifestyle including consumption of excessive alcohol will considerably augment the industry growth.  
 

SynCardia is focusing on development of advanced total artificial heart to strengthen its market position

Few of the notable players operating in the industry are SynCardia, Ekso Bionics, Nipro Corporation, Ottobock, Berlin Heart GmbH, Cochlear Limited, Baxter International, Medtronic, Boston Scientific corporation and Zimmer Biomet. These players are implementing various strategies such as new product launch, acquisitions and collaborations, in order to capitalize high revenue share in artificial organ business.
 

Recent industry developments:

  • In March 2017, Ottobock completed its acquisition of BionX Medical Technologies, a leading company involved in manufacturing of active prosthetic foot and ankle solution. This strategic initiative enabled the company to strengthen its market presence in artificial organ business.
     
  • In September 2016, SynCardia Systems completed its acquisition with Versa Capital Management, LLC. The strategic initiative provided greater financial aid and operational support to the company to flourish globally.
     

Artificial organ market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2014 to 2025, for the following segments:

By Organ Type

  • Artificial kidney
  • Artificial liver
  • Artificial lungs
  • Artificial pancreas
  • Artificial heart
  • Others

By Material Type

  • Silicon
  • Plastic
  • Steel
  • Others

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
    • Russia
    • Poland
    • Turkey
  • Asia Pacific
    • China
    • Japan
    • India
    • Australia
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
       

Frequently Asked Questions (FAQ) :

Artificial organ is a tissue/cell or device-based approach to treat patients with severely damaged organs. These products are mainly used for partial support, regeneration and replacement of diseased, partial functional and damaged organs.
Increasing number of organ failures, immense technological advancement and presence of major market players will be key driving factors for the growth of artificial organs industry in North America.
SynCardia, Ekso Bionics, Nipro Corporation, Ottobock, Berlin Heart GmbH, Cochlear Limited, Baxter International, Medtronic, Boston Scientific corporation and Zimmer Biomet are the key players operating in the worldwide market for artificial organs.

Buy Now

Single User: $5,150 Access to only 1 person; cannot be shared; cannot be printed
Multi User: $7,150 Access for 2 to 5 users only within same department of one company
Enterprise User: $9,150 Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Need a Discount? Get in touch with us for special pricing

Request Discount

Connect with our sales team

Why Global Market Insights, Inc.?

Reliability & accuracy

  • GMI is unparalleled when to comes to the quality of research and information provided to clients. Our unique methodology is designed to ensure a minimum of 90% accuracy to give our clients excellent value on their investment.

Quality & trust


  • BBB Rating - Click to Verify

Customer service

  • Over 200 experts are available across various time-zones, ready to serve clients for their research needs. Our industry experts help clients to design reports customized to their needs.

Security & compliance

We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info X